Fast DNA Analysis Yields Tactical Advantages in the Field
Pleasanton, CA — February 26, 2013 — IntegenX and Science Applications International Corporation (SAIC) announced today that they have signed a teaming agreement to pursue Defense Threat Reduction Agency (DTRA) Indefinite Delivery/Indefinite Quantity (ID/IQ) Awards supporting U.S. needs for detection of weapons of mass destruction. Support provided by IntegenX and SAIC will enable warfighters to complete their missions efficiently and effectively by supplying an integrated system that provides rapid DNA-based identification of biothreat agents.
Rapid DNA analysis is a transformative technology set to fundamentally change the way investigations are conducted by enabling the rapid and definitive identification of bioagents. Rapid DNA technology has the potential to help protect communities through quick detection of biothreat agents and to provide world class DNA identification capabilities to field forward personnel.
In 2012, IntegenX successfully participated in an invitation-only U.S. Department of Defense (DOD) exercise where its RapidHIT™ 200 Human DNA Identification System repeatedly delivered accurate human DNA profiles from swabs, bottles, cans, sputum, hair, saliva and blood. The RapidHIT 200 is a mobile, self-contained DNA identification system that automates and accelerates the process of producing standardized DNA profiles from samples in less than 90 minutes. The teaming agreement pairs SAIC’s biodefense capabilities with IntegenX’s rapid DNA technologies. IntegenX will leverage its RapidHIT System as part of the agreement and SAIC will integrate its software and biodefense capability with the RapidHIT to customize the system for detection of biothreats.
“The RapidHIT System will allow for rapid DNA analysis at the point of action, setting a new standard in the usage of DNA profiles to detect and identify bioagents down to the sub-species level in less than 90 minutes,” said Stevan Jovanovich, Ph.D., President and Chief Executive Officer of IntegenX. “Teaming with SAIC will give the U.S. government further access to IntegenX’s rapid DNA technology. SAIC has shown that they can integrate complex software and detection modalities for support of military biodefense applications.”
About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is a leading developer of rapid human DNA identification technology, next-generation sequencing library preparation, and DNA/RNA ambient temperature stability and storage products. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce products for DNA-based human identity testing and forensics, next generation sequencing and biodefense applications. The company’s expertise and extensive intellectual property includes its patented MOVe™ valve technology, proprietary PrepX™ reagent kits for next generation sequencing library preparation, as well as a portfolio of patented reagents for DNA and RNA preservation including GenTegra® for stabilization and storage of purified DNA and RNA, and GenPlate® for storage of blood samples. For more information, please visit www.integenx.com.
IntegenX, the IntegenX logo, PrepX, MOVe, GenTegra, GenPlate and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.